Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsPanacea biotec

    Panacea Biotec

    Jump to
    • Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y

      Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y

    • Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y

      Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y

    • Stocks to Watch Today: Tata Consumer Products, BPCL, Adani Green Energy, Panacea Biotec, Thyrocare, Bajaj Housing, LTIMindtree in focus on 24 April

      Stocks to Watch Today: Tata Consumer Products, BPCL, Adani Green Energy, Panacea Biotec, Thyrocare, Bajaj Housing, LTIMindtree in focus on 24 April

      Stocks to watch, 24 Apr: Stocks like Syngene International, Wendt India, Supreme Petrochem, 360 ONE WAM, Can Fin Homes, Rallis India, Tata Teleservices (Maharashtra), Tamilnad Mercantile Bank, Filatex India, Biocon, Niva Bupa Health Insurance Company, Spandana Sphoorty Financial, and Bajaj Finance will be in focus on April 24.

    • Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y

      Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y

    • Panacea Biotec shares locked at upper circuit on contract win from UNICEF

      Panacea Biotec shares locked at upper circuit on contract win from UNICEF

      Panacea Biotec Share Price | The share touched a 52-week high of Rs 489.00 and a 52-week low of Rs 112.70 on 12 December, 2024 and 04 June, 2024, respectively. Currently, the stock is trading 11.13 percent below its 52-week high and 285.58 percent above its 52-week low.

    • Stocks to Watch Today: NALCO, BPCL, Gland Pharma, Panacea Biotec, Ramky Infra, Ceigall India, Manorama in focus on 26 December

      Stocks to Watch Today: NALCO, BPCL, Gland Pharma, Panacea Biotec, Ramky Infra, Ceigall India, Manorama in focus on 26 December

      Stocks To Watch Today, Dec 26: Stocks like Bharat Forge, EPACK Durable. UltraTech Cement, Goa Carbon, Macrotech Developers, Religare Enterprises, Aditya Birla Capital, Snowman Logistics, Kalyani Cast-Tech, and Manorama Industries will also be in focus on December 26.

    • Panacea Biotec Consolidated September 2024 Net Sales at Rs 147.35 crore, up 3.03% Y-o-Y

      Panacea Biotec Consolidated September 2024 Net Sales at Rs 147.35 crore, up 3.03% Y-o-Y

    • Panacea Biotec Standalone September 2024 Net Sales at Rs 76.64 crore, down 18.98% Y-o-Y

      Panacea Biotec Standalone September 2024 Net Sales at Rs 76.64 crore, down 18.98% Y-o-Y

    • Panacea Biotec Consolidated June 2024 Net Sales at Rs 115.72 crore, down 10.43% Y-o-Y

      Panacea Biotec Consolidated June 2024 Net Sales at Rs 115.72 crore, down 10.43% Y-o-Y

    • Panacea Biotec Standalone June 2024 Net Sales at Rs 56.88 crore, down 36.38% Y-o-Y

      Panacea Biotec Standalone June 2024 Net Sales at Rs 56.88 crore, down 36.38% Y-o-Y

    • ICMR, Panacea Biotec initiate 1st ever phase-three clinical trial for dengue vaccine in India

      ICMR, Panacea Biotec initiate 1st ever phase-three clinical trial for dengue vaccine in India

      The phase three clinical trial will be conducted across 19 sites in 18 states and union territories, involving more than 10,335 healthy adult participants.

    • Panacea Biotec Consolidated March 2024 Net Sales at Rs 136.46 crore, up 5.84% Y-o-Y

      Panacea Biotec Consolidated March 2024 Net Sales at Rs 136.46 crore, up 5.84% Y-o-Y

    • Panacea Biotec Standalone March 2024 Net Sales at Rs 80.37 crore, up 7.13% Y-o-Y

      Panacea Biotec Standalone March 2024 Net Sales at Rs 80.37 crore, up 7.13% Y-o-Y

    • Panacea Biotec Consolidated December 2023 Net Sales at Rs 150.50 crore, up 30.64% Y-o-Y

      Panacea Biotec Consolidated December 2023 Net Sales at Rs 150.50 crore, up 30.64% Y-o-Y

    • Panacea Biotec Standalone December 2023 Net Sales at Rs 95.23 crore, up 32.32% Y-o-Y

      Panacea Biotec Standalone December 2023 Net Sales at Rs 95.23 crore, up 32.32% Y-o-Y

    • Panacea Biotec shares trade flat after USFDA classifies Baddi facility as OAI

      Panacea Biotec shares trade flat after USFDA classifies Baddi facility as OAI

      A meeting of the board of directors of the company is scheduled to be held on February 13 to consider and approve the unaudited financial results.

    • Bulk deals: Societe Generale, A2Z Online Services sell stake in NIBE, Minerva Ventures Fund buy stake in Cupid

      Bulk deals: Societe Generale, A2Z Online Services sell stake in NIBE, Minerva Ventures Fund buy stake in Cupid

      A2Z Online Services previously held 4.64 percent stake or 6.09 lakh in the company as of September 30, 2023.

    • Panacea Biotec shares rise 5% on pentavalent vaccine launch in India

      Panacea Biotec shares rise 5% on pentavalent vaccine launch in India

      EasyFourPol is the world’s first fully liquid wP-IPV Pentavalent vaccine, which protects children against five deadly diseases i.e. Diphtheria, Tetanus, Pertussis, Polio, and invasive infections caused by Haemophilus Influenza Type b.

    • Panacea Biotec Standalone September 2023 Net Sales at Rs 94.59 crore, up 94.07% Y-o-Y

      Panacea Biotec Standalone September 2023 Net Sales at Rs 94.59 crore, up 94.07% Y-o-Y

    • Panacea Biotec arm launches cancer drug in Canadian market; shares trade higher

      Panacea Biotec arm launches cancer drug in Canadian market; shares trade higher

      Paclitaxel Protein-Bound Particles is indicated for the treatment of metastatic breast cancer, non-small cell lung cancer, and adenocarcinoma of the pancreas.

    • Panacea Biotec hits 52-week high on Serum Institute selling off 4 lakh shares

      Panacea Biotec hits 52-week high on Serum Institute selling off 4 lakh shares

      According to the data published by the NSE, the vaccine maker sold its shares in the company for the second time in the ongoing quarter after having offloaded 5 lakh shares in August at an average price of Rs 146.31.

    • Panacea Biotec Consolidated June 2023 Net Sales at Rs 129.19 crore, up 16.7% Y-o-Y

      Panacea Biotec Consolidated June 2023 Net Sales at Rs 129.19 crore, up 16.7% Y-o-Y

    • Panacea Biotec Standalone June 2023 Net Sales at Rs 89.41 crore, up 45.76% Y-o-Y

      Panacea Biotec Standalone June 2023 Net Sales at Rs 89.41 crore, up 45.76% Y-o-Y

    • Panacea Biotec Consolidated March 2023 Net Sales at Rs 128.93 crore, down 8.38% Y-o-Y

      Panacea Biotec Consolidated March 2023 Net Sales at Rs 128.93 crore, down 8.38% Y-o-Y

    • Panacea Biotec Standalone March 2023 Net Sales at Rs 75.02 crore, up 80.77% Y-o-Y

      Panacea Biotec Standalone March 2023 Net Sales at Rs 75.02 crore, up 80.77% Y-o-Y

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347